Work

Nuclear CD133 expression predicts poor prognosis for hepatocellular carcinoma.

Year: 2018

Type: article

Abstract: = 0.057). Nuclear CD133 expression can potentially serve as a biomarker for clinical diagnosis and prognosis of HCC.

Source: PubMed

Authors: Gui-Fang Yu, Xian Lin, Rong-Cheng Luo, Wei-Yi Fang

Institutions: Southern Medical University, Guangzhou Medical University

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W3002701225

FWCI: 0.995

Cites: 24

Cited by: 13

Related to: 10